Barclays PLC Boosts Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK)
Barclays PLC grew its position in Anika Therapeutics, Inc. (NASDAQ:ANIK – Free Report) by 6.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 34,757 shares of the biotechnology company’s stock after purchasing an additional 2,093 shares during the period. Barclays PLC’s holdings in Anika Therapeutics […]
Barclays PLC grew its position in Anika Therapeutics, Inc. (NASDAQ:ANIK – Free Report) by 6.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 34,757 shares of the biotechnology company’s stock after purchasing an additional 2,093 shares during the period. Barclays PLC’s holdings in Anika Therapeutics […]
